Skip to main content
INVITES BIOCORE CO., LTD logo

INVITES BIOCORE CO., LTD — Investor Relations & Filings

Ticker · 216400 ISIN · KR7216400002 KO Professional, scientific and technical activities
Open in API
Filings indexed 169 across all filing types
Latest filing 2023-03-29 Declaration of Voting R…
Country KR South Korea
Listing KO 216400

About INVITES BIOCORE CO., LTD

https://www.bio-core.com/eng/main/main.…

INVITES BIOCORE CO., LTD. is a Contract Research Organization (CRO) that provides comprehensive services to support new drug development. Established in 2001, the company partners with pharmaceutical firms, research institutes, and medical institutions. Its primary services include bioanalytical testing, central lab services, and clinical trial support. The company also specializes in genomic analysis, offering genetic and cell screening, individual genome analysis, and related services to facilitate the advancement of precision medicine and personalized healthcare.

Recent filings

Filing Released Lang Actions
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official announcement of the results of a General Meeting of Shareholders (정기주주총회 결과). It details the approval of financial statements, director appointments, and remuneration limits. This falls under the category of Declaration of Voting Results & Voting Rights Announcements (DVA), as it reports the outcome of shareholder votes at an AGM.
2023-03-29 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a regulatory filing titled '감사보고서 제출' (Submission of Audit Report) from the company '인바이츠바이오코아'. It provides a summary of the audit opinion (적정/Unqualified), key financial data (assets, liabilities, revenue, profit/loss), and auditor information (삼일회계법인). While it contains financial data, it is a standard regulatory disclosure form used in the Korean market to announce the completion and submission of the audit report to the regulator, rather than the full audit report document itself. Therefore, it is classified as a Regulatory Filing. FY 2022
2023-03-21 Korean
사업보고서 (2022.12)
Annual Report Classification · 100% confidence The document is a formal '사업보고서' (Business Report) for the fiscal year 2022 (2022.01.01 ~ 2022.12.31), submitted to the Financial Services Commission and the Korea Exchange. It contains comprehensive sections including company overview, business description, financial statements, management discussion and analysis, and governance details. This structure corresponds to the standard annual report filing required for public companies in Korea, which maps to the 10-K category in the provided schema. FY 2022
2023-03-21 Korean
[기재정정]주주총회소집공고
AGM Information Classification · 98% confidence The document is a formal 'Correction Report' (정정신고) regarding a 'Notice of Convocation of General Meeting of Shareholders' (주주총회소집공고). It contains detailed financial statements (Balance Sheet, Income Statement, Statement of Changes in Equity, Cash Flow Statement) and extensive notes to the financial statements, which are typically part of an annual or interim report package. However, because this specific document is a regulatory filing issued to correct previously submitted information for a shareholder meeting, it falls under the category of regulatory filings that provide supplementary or corrected financial data for governance purposes. Given the structure and the context of a shareholder meeting notice correction, it is best classified as a Regulatory Filing.
2023-03-21 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal 'Notice of General Meeting of Shareholders' (주주총회소집공고) for Invites Bio Core Co., Ltd. It includes the meeting date, location, agenda items (financial statements, director appointments, remuneration limits), and detailed management reference materials (business overview, industry status, and governance information). This is a standard proxy statement/notice document sent to shareholders to inform them of an upcoming meeting and provide necessary information for voting.
2023-03-14 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집 결의) issued by Invites BioCore. It outlines the date, location, agenda items (financial statement approval, director appointments, and remuneration limits), and details regarding the board's resolution. This document serves as the official notification and proxy-related information sent to shareholders to inform them of the upcoming meeting and the matters to be voted upon. According to the provided definitions, this fits the Proxy Solicitation & Information Statement (PSI) category.
2023-03-08 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.